Second Generation Biofuels Critical to Ensure Compliance with Future Biofuel Mandates in Europe

First generation biofuels are outdated and second generation biofuels are not yet commercially feasible. Improvements in conversion processes of second generation biofuels will be an important factor in regions such as Europe complying with the 10 per cent biofuels mandate by 2020. Third and fourth generation biofuels are still in their infancy. Consequently, Europe is expected to achieve only 5 per cent against a biofuels target of 5.75 per cent by 2010.

At the same time, end consumers are apprehensive about the increase in food prices, because of alternate demand for biofuels. This is hampering the sales of biofuel vehicles. Worldwide production of biofuels exceeded 12 billion gallons in 2005, which is only a small fraction of the total fuel demand.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the executive report on assessment of the global biofuels market and implications to Europe, then send an e-mail to Anna Anlauft, Corporate Communications, at [email protected], with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

"Although the primary aim of promoting biofuels is to reduce dependence on fossil fuels, regional discrepancies in adoption rates and strategies have led to a complex global biofuels scenario," notes Frost & Sullivan (http://www.automotive.frost.com) Research Manager Kaushik Madhavan. "On the one hand, countries like Brazil and Sweden are pushing hard for increased bio-content with mandates for both OEMs and oil companies. In other regions, the bio-content mandate is staggered mainly due to feedstock concerns and end consumer fears related to the food vs. fuel debate."

The cost disadvantage of producing biofuels is significantly higher than the benefits achieved from their use. This scenario is unlikely to change until 2015, even with the use of second generation biofuels. Challenges related to warranty are also dampening market prospects; OEMs cannot offer any assurances or guarantees in the event of using high biofuels content, owing to the absence of certification and standardised vehicle testing guidelines.

Regional variations and regulations pertaining to the certification of biofuels have resulted in qualitative differences. OEMs are concerned about sourcing feedstock from Southeast Asian countries citing quality issues. Global certification of biofuels will be necessary to ensure compatibility across regions.

"Diesel exhaust after-treatment is an important concern in applications with high biofuels content," adds Madhavan. "The efficiency of DPF is compromised if the biofuel content exceeds 5-6 per cent. OEMs using the post-injection based regeneration techniques are not confident of authorising high bio-content usage in their vehicles."

Biofuel mandates for gasoline engines are energy based; moving to a volume-based replacement will increase ethanol content by up to 50 per cent. This will reduce the specific power output, although OEMs are working towards sensor-based engine management systems to ensure minimal impact on driving characteristics.

"Farming subsidies given by local governments are becoming critical as farmers choose biofuels over food crops," comments Madhavan. "Countries with high biofuel consumptions, such as Sweden, are importing feedstock from countries like Brazil thereby increasing food prices. Vast areas of forest land have been erased in Malaysia by farmers wanting to make quick money by exporting feedstock to Europe."

EU research schemes allow funding for biofuels only on a limited scale. The involvement of private research companies and universities, in collaboration with OEMs and oil companies, will promote greater maturity in 2nd generation processes.

"Second generation biofuels will be commercially successful only if the price of extracting biofuels is lower than or equal to the price of producing fossil fuels," concludes Madhavan. "Consortia involving oil companies, OEMs, universities and equity companies will bring about stability in processes and help attain economic feasibility in the production of second generation biofuels."

Executive Report on Assessment of the Global Biofuels Market and Implications to Europe is part of the Automotive & Transportation Growth Partnership Services programme, which also includes research in the following markets: Strategic Review of Global Biofuels Market for Automotive Applications, Strategic Analysis of the European Market for HCCI Technologies, Strategic Assessment of the ACEA Agreement and its Implications on European OEMs, Strategic Assessment of Euro 5 and Euro 6 Limits for Passenger Vehicles, SWOT Analysis of Key Engine Emission Control Technologies and Strategic Analysis of in-car Green Technologies. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.frost.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.